Primary Biliary Cholangitis Associated with Celiac Disease, Lupus, and Hashimoto’s Thyroiditis: A Case Report
DOI:
https://doi.org/10.22516/25007440.1476Keywords:
Primary biliary cholangitis, systemic lupus erythematosus, celiac disease, Hashimoto’s thyroiditisAbstract
Introduction: The coexistence of two or more autoimmune diseases defines multiple autoimmune syndrome. Primary biliary cholangitis (PBC) may occur in association with other immune-mediated conditions. A case of PBC associated with systemic lupus erythematosus (SLE), celiac disease (CD), and Hashimoto’s thyroiditis (HT) is described.
Case report: A 45-year-old woman presented with cholestatic liver enzyme abnormalities and positive autoantibodies. She had a history of HT and a family history of CD. Serology showed positive anti-endomysial antibodies, anti–tissue transglutaminase IgA 117 U/mL, positive AMA-M2, ANA 1:320, positive anti-dsDNA, and decreased C3/C4. Duodenal biopsy revealed villous atrophy, and liver biopsy demonstrated granulomas, bile duct injury, and portal inflammation with portal fibrosis, confirming PBC. A gluten-free diet, ursodeoxycholic acid (15 mg/kg/day), hydroxychloroquine (400 mg/day), prednisone (0.5 mg/kg with taper), and azathioprine were initiated. The patient showed normalization of liver biochemistry and clinical improvement.
Discussion: Polyautoimmunity in PBC is well recognized and commonly involves thyroid disorders, SLE, and CD. This case illustrates the need for targeted screening for associated autoimmune diseases and multidisciplinary management. The presence of multiple autoantibodies and characteristic histological findings guided diagnosis and treatment.
Conclusion: In patients with PBC, concomitant autoimmune diagnoses should be considered; early detection and comprehensive management optimize outcomes.
Downloads
References
Ma D, Ma J, Zhao C, Tai W. Reasons why women are more likely to develop primary biliary cholangitis. Heliyon. 2024;10(4):e25634. https://doi.org/10.1016/j.heliyon.2024.e25634
Anaya JM, Rojas-Villarraga A, García-Carrasco M. The autoimmune tautology: from polyautoimmunity and familial autoimmunity to the autoimmune genes. Autoimmune Dis. 2012;2012:297193. https://doi.org/10.1155/2012/297193
Anaya JM, Corena R, Castiblanco J, Rojas-Villarraga A, Shoenfeld Y. The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert Rev Clin Immunol. 2007;3(4):623-35. https://doi.org/10.1586/1744666X.3.4.623
Floreani A, Franceschet I, Cazzagon N, Spinazzè A, Buja A, Furlan P, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48(2-3):192-7. https://doi.org/10.1007/s12016-014-8427-x
Abu Hanna F, Sirkin M, Ilovich BS, Egbarieh R, Tatour S, Lahad A, et al. Parameters associated with the development of autoimmune diseases in pediatric onset celiac disease. Eur J Pediatr. 2025;184(3):199. https://doi.org/10.1007/s00431-025-06028-5
Pham-Dobor G, Kaltenecker P, Temesfoi V, Bajnok L, Nemes O, Bodis B, et al. Systematic Analysis and Network Mapping of Disease Associations in Autoimmune Polyglandular Syndrome. J Clin Endocrinol Metab. 2025;110(6):1716-1728. https://doi.org/10.1210/clinem/dgae701
Chaudrey KH. ACG Guideline: Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2023;118(1):23. https://doi.org/10.14309/ajg.0000000000002111
Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998;42(1):120-122. https://doi.org/10.1136/gut.42.1.120
Sorensen HT, Thulstrup AM, Blomqvist P, Nørgaard B, Fonager K, Ekbom A. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 1999;44(5):736-738. https://doi.org/10.1136/gut.44.5.736
Sjöberg K, Lindgren S, Eriksson S. Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict coeliac disease in patients with chronic liver disease. Scand J Gastroenterol 1997;32(11):1162-7. https://doi.org/10.3109/00365529709002997
Volta U, De Franceschi L, Molinaro N, Cassani F, Muratori L, Lenzi M, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43(10):2190-2195. https://doi.org/10.1023/A:1026650118759
Bardella MT, Quatrini M, Zuin M, Podda M, Cesarini L, Velio P, et al. Screening patients with celiac disease for primary biliary cirrhosis and vice versa. Am J Gastroenterol. 1997;92(9):1524-1526.
Chatzicostas C, Roussomoustakaki M, Drygiannakis D, Niniraki M, Tzardi M, Koulentaki M, et al. Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete. BMC Gastroenterol. 2002;2:5. https://doi.org/10.1186/1471-230X-2-5
Narciso-Schiavon JL, Schiavon LL. To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol. 2017;23(5):776-791. https://doi.org/10.3748/wjg.v23.i5.776
Vignoli A, Orlandini B, Tenori L, Biagini MR, Milani S, Renzi D, et al. Metabolic Signature of Primary Biliary Cholangitis and Its Comparison with Celiac Disease. J Proteome Res. 2019;18(3):1228-1236. https://doi.org/10.1021/acs.jproteome.8b00849
Kuiper EM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2010;8(6):530-4. https://doi.org/10.1016/j.cgh.2010.03.004
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145-172. https://doi.org/10.1016/j.jhep.2017.03.022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista colombiana de Gastroenterología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

| Article metrics | |
|---|---|
| Abstract views | 544 |
| Galley views | 281 |
| PDF Views | 249 |
| HTML views | 0 |
| Other views | 32 |














